128 related articles for article (PubMed ID: 37028462)
1. Bone sialoprotein promotes lung cancer osteolytic bone metastasis via MMP14-dependent mechanisms.
Chen WC; Chang AC; Tsai HC; Liu PI; Huang CL; Guo JH; Liu CL; Liu JF; Huynh Hoai Thuong L; Tang CH
Biochem Pharmacol; 2023 May; 211():115540. PubMed ID: 37028462
[TBL] [Abstract][Full Text] [Related]
2. Targeted overexpression of BSP in osteoclasts promotes bone metastasis of breast cancer cells.
Tu Q; Zhang J; Fix A; Brewer E; Li YP; Zhang ZY; Chen J
J Cell Physiol; 2009 Jan; 218(1):135-45. PubMed ID: 18756497
[TBL] [Abstract][Full Text] [Related]
3. Bone sialoprotein, matrix metalloproteinase 2, and alpha(v)beta3 integrin in osteotropic cancer cell invasion.
Karadag A; Ogbureke KU; Fedarko NS; Fisher LW
J Natl Cancer Inst; 2004 Jun; 96(12):956-65. PubMed ID: 15199115
[TBL] [Abstract][Full Text] [Related]
4. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.
Valverde P; Tu Q; Chen J
J Bone Miner Res; 2005 Sep; 20(9):1669-79. PubMed ID: 16059638
[TBL] [Abstract][Full Text] [Related]
5. Bone sialoprotein-αvβ3 integrin axis promotes breast cancer metastasis to the bone.
Wang L; Song L; Li J; Wang Y; Yang C; Kou X; Xiao B; Zhang W; Li L; Liu S; Wang J
Cancer Sci; 2019 Oct; 110(10):3157-3172. PubMed ID: 31432600
[TBL] [Abstract][Full Text] [Related]
6. Sustained conditional knockdown reveals intracellular bone sialoprotein as essential for breast cancer skeletal metastasis.
Kovacheva M; Zepp M; Berger SM; Berger MR
Oncotarget; 2014 Jul; 5(14):5510-22. PubMed ID: 24980816
[TBL] [Abstract][Full Text] [Related]
7. Bone sialoprotein does not interact with pro-gelatinase A (MMP-2) or mediate MMP-2 activation.
Hwang Q; Cheifetz S; Overall CM; McCulloch CA; Sodek J
BMC Cancer; 2009 Apr; 9():121. PubMed ID: 19386107
[TBL] [Abstract][Full Text] [Related]
8. Bone sialoprotein stimulates focal adhesion-related signaling pathways: role in migration and survival of breast and prostate cancer cells.
Gordon JA; Sodek J; Hunter GK; Goldberg HA
J Cell Biochem; 2009 Aug; 107(6):1118-28. PubMed ID: 19492334
[TBL] [Abstract][Full Text] [Related]
9. BSP gene silencing inhibits migration, invasion, and bone metastasis of MDA-MB-231BO human breast cancer cells.
Wang J; Wang L; Xia B; Yang C; Lai H; Chen X
PLoS One; 2013; 8(5):e62936. PubMed ID: 23667544
[TBL] [Abstract][Full Text] [Related]
10. Bone sialoprotein mediates the tumor cell-targeted prometastatic activity of transforming growth factor beta in a mouse model of breast cancer.
Nam JS; Suchar AM; Kang MJ; Stuelten CH; Tang B; Michalowska AM; Fisher LW; Fedarko NS; Jain A; Pinkas J; Lonning S; Wakefield LM
Cancer Res; 2006 Jun; 66(12):6327-35. PubMed ID: 16778210
[TBL] [Abstract][Full Text] [Related]
11. SB225002 inhibits prostate cancer invasion and attenuates the expression of BSP, OPN and MMP‑2.
Xu M; Jiang H; Wang H; Liu J; Liu B; Guo Z
Oncol Rep; 2018 Aug; 40(2):726-736. PubMed ID: 29917166
[TBL] [Abstract][Full Text] [Related]
12. Glucocorticoid regulation of bone sialoprotein (BSP) gene expression. Identification of a glucocorticoid response element in the bone sialoprotein gene promoter.
Ogata Y; Yamauchi M; Kim RH; Li JJ; Freedman LP; Sodek J
Eur J Biochem; 1995 May; 230(1):183-92. PubMed ID: 7601099
[TBL] [Abstract][Full Text] [Related]
13. Predictive significance of bone sialoprotein and osteopontin for bone metastases in resected Chinese non-small-cell lung cancer patients: a large cohort retrospective study.
Zhang L; Hou X; Lu S; Rao H; Hou J; Luo R; Huang H; Zhao H; Jian H; Chen Z; Liao M; Wang X
Lung Cancer; 2010 Jan; 67(1):114-9. PubMed ID: 19376608
[TBL] [Abstract][Full Text] [Related]
14. Bone sialoprotein supports breast cancer cell adhesion proliferation and migration through differential usage of the alpha(v)beta3 and alpha(v)beta5 integrins.
Sung V; Stubbs JT; Fisher L; Aaron AD; Thompson EW
J Cell Physiol; 1998 Sep; 176(3):482-94. PubMed ID: 9699501
[TBL] [Abstract][Full Text] [Related]
15. Expression of bone sialoprotein in human lung cancer.
Bellahcène A; Maloujahmoum N; Fisher LW; Pastorino H; Tagliabue E; Ménard S; Castronovo V
Calcif Tissue Int; 1997 Sep; 61(3):183-8. PubMed ID: 9262507
[TBL] [Abstract][Full Text] [Related]
16. Over-expression of bone sialoprotein enhances bone metastasis of human breast cancer cells in a mouse model.
Zhang JH; Tang J; Wang J; Ma W; Zheng W; Yoneda T; Chen J
Int J Oncol; 2003 Oct; 23(4):1043-8. PubMed ID: 12963984
[TBL] [Abstract][Full Text] [Related]
17. Silencing of skeletal metastasis-associated genes impairs migration of breast cancer cells and reduces osteolytic bone lesions.
Reufsteck C; Lifshitz-Shovali R; Zepp M; Bäuerle T; Kübler D; Golomb G; Berger MR
Clin Exp Metastasis; 2012 Jun; 29(5):441-56. PubMed ID: 22407340
[TBL] [Abstract][Full Text] [Related]
18. Expression of bone sialoprotein in primary human breast cancer is associated with poor survival.
Bellahcène A; Menard S; Bufalino R; Moreau L; Castronovo V
Int J Cancer; 1996 Aug; 69(4):350-3. PubMed ID: 8797881
[TBL] [Abstract][Full Text] [Related]
19. Bone sialoprotein binding to matrix metalloproteinase-2 alters enzyme inhibition kinetics.
Jain A; Fisher LW; Fedarko NS
Biochemistry; 2008 Jun; 47(22):5986-95. PubMed ID: 18465841
[TBL] [Abstract][Full Text] [Related]
20. Functional defects in cementoblasts with disrupted bone sialoprotein functional domains, in vitro.
Chavez MB; Tan MH; Kolli TN; Andras NL; Foster BL
Bone; 2024 Feb; 179():116961. PubMed ID: 37951522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
